Download PDF
Horm Metab Res 2020; 52(08): 551-552
DOI: 10.1055/a-1217-1529
Editorial

A Century After the Description of “Hormones”, Our Golden Jubilee Celebration Goes on with What is New in Endocrine Oncology: And a Lot is New!

Constantine A. Stratakis
1   Pediatrics, Endocrinology & Medical Genetics, Bethesda, Maryland, USA
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

About 3000 thousand years ago Marcus Aurelius said: “Time is a sort of river of passing events, and strong is its current; no sooner is a thing brought to sight than it is swept by and another takes its place, and this too will be swept away…” [1].



Publication History

Received: 13 July 2020

Accepted: 13 July 2020

Article published online:
13 August 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • References

  • 1 Marcus Aurelius. Meditations. Tanslated by Hays G New York, NY: Modern Library; (paperback edition) 2003
  • 2 Stratakis CA. Pheochromocytomas: Fabulous, fascinating, and first (in everything)!. Horm Metab Res 2019; 51: 401-402
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Stratakis CA. Medical treatment of pituitary adenomas: A celebration of endocrinology (and oncology)!. Horm Metab Res 2020; 52: 7
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Roth J, Qureshi S, Whitford I. et al. Insulin’s discovery: New insights on its ninetieth birthday. Diabetes Metab Res Rev 2012; 28: 293-304
    CrossrefPubMedGoogle Scholar
  • 5 Modlin IM, Kidd M. Ernest Starling and the discovery of secretin. J Clin Gastroenterol 2001; 32: 187-192
    CrossrefPubMedGoogle Scholar
  • 6 Vasilev V, Daly AF, Zacharieva S. et al. Clinical and molecular update on genetic causes of pituitary adenomas. Horm Metab Res 2020; 52: 553-561
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Chahal HS, Stals K, Unterländer M. et al. AIP mutation in pituitary adenomas in the 18th century and today. N Engl J Med 2011; 364: 43-50
    CrossrefPubMedGoogle Scholar
  • 8 de Herder WW. The history of acromegaly. Neuroendocrinology 2016; 103: 7-17
    CrossrefPubMedGoogle Scholar
  • 9 Markantes GK, Theodoropoulou A, Armeni AK. et al. Cyclopes and Giants: From Homer’s Odyssey to contemporary genetic diagnosis. Hormones (Athens) 2016; 15: 459-463
    PubMedGoogle Scholar
  • 10 Gheorghiu ML, Negreanu F, Fleseriu M. Updates in the medical treatment of pituitary adenomas. Horm Metab Res 2020; 52: 8-24
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Araque KA, Gubbi S, Klubo-Gwiezdzinska J. Updates on the management of thyroid cancer. Horm Metab Res 2020; 52: 562-577
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Simonds WF. Clinical and molecular genetics of primary hyperparathyroidism. Horm Metab Res 2020; 52: 578-587
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Ilanchezhian M, Khan S, Okafor S. et al. Update on the treatment of medullary thyroid carcinoma in patients with multiple endocrine neoplasia type 2. Horm Metab Res 2020; 52: 588-597
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Berthon A, Bertherat J. Update of genetic and molecular causes of adrenocortical hyperplasias causing Cushing syndrome. Horm Metab Res 2020; 52: 598-606
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Plaska SW, Liu C-J, Lim JS. et al. Targeted RNAseq of formalin-fixed paraffin-embedded tissue to differentiate among benign and malignant adrenal cortical tumors. Horm Metab Res 2020; 52: 607-613
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Tsoli M, Alexandraki K, Xanthopoulos C. et al. Medical treatment of gastrointestinal neuroendocrine neoplasms. Horm Metab Res 2020; 52: 614-620
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Melmed S. Acromegaly, “Section 8 The Endocrine System”. In: Rakel RE Ed. Conn’s Current Therapy. Philadelphia: W. B. Saunders; 1991: 565–568
  • 18 Kamilaris CT, Chrousos GP. Cushing’s Syndrome, “Section 8 The Endocrine System”. In: Rakel RE, Ed. Conn’s Current Therapy. Philadelphia: W. B. Saunders; 1991: 572–578
  • 19 Nankova A, Yaneva M, Elenkova A. et al. Cushing’s syndrome: A historic review of the treatment strategies and corresponding outcomes in a single tertiary center over the past half-century. Horm Metab Res 2018; 50: 280-289
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Afshari A, Keil M, Lyssikatos C. et al. Optical imaging technology: A useful tool to identify remission in cushing disease after surgery. Horm Metab Res 2019; 51: 120-126 ; Correction: Horm Metab Res 2019; 51: e1
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Petersenn S. Management of aggressive pituitary tumors – A 2019 update. Horm Metab Res 2019; 51: 755-764
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Crouzeix G, Morello R, Thariat J. et al. Quality of life but not cognition is impacted by radiotherapy in patients with non-functioning pituitary adenoma. Horm Metab Res 2019; 51: 178-185
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Daskalakis K, Tsoli M, Alexandraki K. et al. Magnetic resonance imaging or endoscopic ultrasonography for detection and surveillance of pancreatic neuroendocrine neoplasms in patients with multiple endocrine neoplasia type 1?. Horm Metab Res 2019; 51: 580-585
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Nagayama Y. Thyroid autoimmunity and thyroid cancer – the pathogenic connection: A 2018 update. Horm Metab Res 2018; 50: 922-931
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Tsoli M, Alexandraki KI, Spei M-E. Anti-tumor activity and safety of multikinase inhibitors in advanced and/or metastatic thyroid cancer: a systematic review and network meta-analysis of randomized controlled trials. Horm Metab Res 2020; 52: 25-31
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Du Q, Yao D-S, Wang Y-W. Research progress on lncRNA functions and mechanisms in pituitary adenomas. Horm Metab Res 2020; 52: 280-288
    Article in Thieme ConnectPubMedGoogle Scholar